List of people who will participate at workshop for convergence environments. Will be updated.
Neuroscience
| Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial project idea |
|---|---|---|
|
Camila Esguerra |
Disease models, Drug discovery, Tissue xenografting, Toxicology |
|
|
Steffen Maude Fagerland |
fNIRS, fMRI, brain training |
|
|
Autophagy, kidney cancer, drosophila |
Autophagy in sleep and restoration |
|
| Siri Leknes |
Applying psychology to understand health consequences of clinical decisions and clinical encounters, Opioid effects; pain; addiction; anaestesia, Affective neuroscience, social neuroscience |
Applying psychology to understand consequences of clinical decisions |
|
Niamh MacSweeney |
Hormonal contraceptive use, adolescent brain development, mental health risk, women's health, puberty, cognitive neuroscience |
|
| Anders Malthe-S?rensen |
Neuroscience, gene therapy, de novo protein design, machine learning, docking simulations |
Our goal is to develop a platform technology for gene therapies for central nervous system diseases combining generative AI models for construct and capsid development, in vitro and in vivo experimental pipelines, and an integral RRI approach to address fundamental relevant ethical issues. |
| John N. Parker |
I am a sociologist of science with expertise in how to best create the kinds of organizations, groups, and social interactions that best facilitate creative interdisciplinary research. My interest is in joining a team to help them plan how they might best organize themselves for interdisciplinary success. |
|
|
Brain development, adolescents, mental health, MRI, environmental factors |
Personalised medicine
| Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial |
|---|---|---|
| Nina Edin |
Radiation physics, radiobiology |
Convergence environment on Radiation and Health |
| Jorrit Enserink |
Immunotherapy; prediction of outcome; cancer heterogeneity; patient stratification; drug screening; leukemia |
Immunotherapy can provide remarkable clinical benefit to cancer patients; however, only a subset of patients responds to immunotherapeutic treatment. Being able to differentiate between responders and non-responders will have a major impact on the accuracy of patient stratification and thereby on treatment outcome. The goal of our environment will be to bring together experts in the field of cancer biology, mathematical modeling, and law/ethics to develop novel personalised medicine methods for immunotherapeutic treatment of a variety of cancer types. |
|
Camila Esguerra |
Disease models, Drug discovery, Tissue xenografting, Toxicology |
|
|
Steffen Maude Fagerland |
fNIRS, fMRI, brain training |
|
|
Autophagy, kidney cancer, drosophila |
Autophagy in sleep and restoration |
|
| Siri Leknes |
Applying psychology to understand health consequences of clinical decisions and clinical encounters, Opioid effects; pain; addiction; anaestesia, Affective neuroscience, social neuroscience |
Applying psychology to understand consequences of clinical decisions |
| John N. Parker |
I am a sociologist of science with expertise in how to best create the kinds of organizations, groups, and social interactions that best facilitate creative interdisciplinary research. My interest is in joining a team to help them plan how they might best organize themselves for interdisciplinary success. |
|
|
Cancer epigenetics, gene expression control, enhancer malfunction and epigenome reprogramming by transcription factors, next-generation sequencing and single cell multomics |
Understand the role of non-genetic mechanisms such as enhancer and epigenome reprogramming in cancer initiation, progression, metastasis and treatment resistance. Using high resolution enhancer landscapes in accessible chromatin and gene expression data from single cell analysis. |
|
Innovative health technologies and drug development
| Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial |
|---|---|---|
| Nina Edin |
Radiation physics, radiobiology |
Convergence environment on Radiation and Health |
| Jorrit Enserink |
Immunotherapy; prediction of outcome; cancer heterogeneity; patient stratification; drug screening; leukemia |
Immunotherapy can provide remarkable clinical benefit to cancer patients; however, only a subset of patients responds to immunotherapeutic treatment. Being able to differentiate between responders and non-responders will have a major impact on the accuracy of patient stratification and thereby on treatment outcome. The goal of our environment will be to bring together experts in the field of cancer biology, mathematical modeling, and law/ethics to develop novel personalised medicine methods for immunotherapeutic treatment of a variety of cancer types. |
|
Camila Esguerra |
Disease models, Drug discovery, Tissue xenografting, Toxicology |
|
|
Steffen Maude Fagerland |
fNIRS, fMRI, brain training |
|
| Anders Malthe-S?rensen |
Neuroscience, gene therapy, de novo protein design, machine learning, docking simulations |
Our goal is to develop a platform technology for gene therapies for central nervous system diseases combining generative AI models for construct and capsid development, in vitro and in vivo experimental pipelines, and an integral RRI approach to address fundamental relevant ethical issues. |
| John N. Parker |
I am a sociologist of science with expertise in how to best create the kinds of organizations, groups, and social interactions that best facilitate creative interdisciplinary research. My interest is in joining a team to help them plan how they might best organize themselves for interdisciplinary success. |
|
|
Cancer epigenetics, gene expression control, enhancer malfunction and epigenome reprogramming by transcription factors, next-generation sequencing and single cell multomics |
Understand the role of non-genetic mechanisms such as enhancer and epigenome reprogramming in cancer initiation, progression, metastasis and treatment resistance. Using high resolution enhancer landscapes in accessible chromatin and gene expression data from single cell analysis. |
|
Health and society
| Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial |
|---|---|---|
| Nina Edin |
Radiation physics, radiobiology |
Convergence environment on Radiation and Health |
|
Camila Esguerra |
Disease models, Drug discovery, Tissue xenografting, Toxicology |
|
| Siri Leknes |
Applying psychology to understand health consequences of clinical decisions and clinical encounters, Opioid effects; pain; addiction; anaestesia, Affective neuroscience, social neuroscience |
Applying psychology to understand consequences of clinical decisions |
| Julien Mayor |
Language acquisition, cognitive development, eye-tracking, language assessments, online data collection |
How does variability in the learning environment impact language acquisition? We plan on looking into sources of variability in the learning environment of young children (dialects, languages, contexts, etc) and their impact on early language development, as well as on their potential effect on language delays and impairments. |
| John N. Parker |
I am a sociologist of science with expertise in how to best create the kinds of organizations, groups, and social interactions that best facilitate creative interdisciplinary research. My interest is in joining a team to help them plan how they might best organize themselves for interdisciplinary success. |
|
|
Genetic research, education, mental and physical health, register data, causal inference, inclusion and diversity, sociogenomics. |
How to achieve equality and inclusion in the face of growing societal challenges? Interdisciplinary project (economics of education and health, sociology, psychology and genetic epidemiology) combining methodological approaches (experimental, quasi-experimental, machine learning and genetically sensitive designs) and unparalleled data linkage (register data and detailed survey and genomic family data). |
|
|
Brain development, adolescents, mental health, MRI, environmental factors |
||
No specified topic
| Name | Research topic(s) of interest and/or competence |
Title or short description (2-3 sentences) of initial |
|---|---|---|